Enovis Corporation (0I1B.L)

51,07 -0,65 (-1,26%) Alla chiusura: 02:32PM BST

Enovis Corporation

2711 Centerville Road
Suite 400
Wilmington, DE 19808
United States
302 252 9160
https://www.enovis.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 6.550

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Matthew L. Trerotola	CEO & Chairman	3,35M	N/D	1967
Mr. Phillip Benjamin Berry	Senior VP & CFO	1,08M	N/D	1979
Ms. Patricia A. Lang	Senior VP & Chief Human Resources Officer	1,01M	N/D	1959
Mr. Daniel A. Pryor	Executive Vice President of Strategy & Business Development	1,29M	N/D	1968
Mr. Brady R. Shirley	Executive Advisor & Director	2,02M	N/D	1966
Mr. John Kleckner	VP, Controller & Chief Accounting Officer	N/D	N/D	1977
Derek Leckow	Vice President of Investor Relations	N/D	N/D	N/D
Mr. Bradley J. Tandy	Senior VP & Chief Legal Officer	N/D	N/D	1959
Katie Sweet	Vice President of Corporate Communication	N/D	N/D	N/D
Mr. Terry Ross	Group President Prevention & Recovery	N/D	N/D	1970

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Governance aziendale

L'ISS Governance QualityScore di Enovis Corporation al 1 maggio 2024 è 2. I criteri di valutazione fondamentali sono revisione: 5; Consiglio di Amministrazione: 3; diritti degli azionisti: 2; retribuzione: 4.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.